Date: September 17, 2024
Broker: CGS-CIMB Securities
Company Overview
Sino Biopharmaceutical Ltd (Stock Code: 1177) is a major pharmaceutical company based in Hong Kong. It focuses on the research, development, production, and distribution of biopharmaceutical products. The company is a significant player in the healthcare and pharmaceutical sectors in Asia.
Stock Recommendation: Technical Buy
Sino Biopharmaceutical Ltd is currently rated as a Technical Buy. The stock has multiple entry levels, offering an attractive opportunity for investors interested in the healthcare sector.
Entry and Stop Loss Levels
- Entry Prices: The recommended entry prices are 3.27, 3.03, and 2.72 HKD.
- Stop Loss: The stop-loss level is set at 2.57 HKD, providing protection in case of downward price movements.
Target Prices
The stock has a range of target prices, suggesting significant upside potential:
- Target 1: 3.68 HKD
- Target 2: 4.04 HKD
- Target 3: 4.50 HKD
- Target 4: 5.10 HKD
Investment Rationale
The technical indicators for Sino Biopharmaceutical Ltd are favorable, reflecting a strong potential for price growth. The recommended entry points and target levels offer a structured approach to benefit from this potential. Investors should monitor the stock closely and adhere to stop-loss levels to manage risk.
